Levetiracetam and Snoring - a phase IV clinical study of FDA data

Summary:

Snoring is reported as a side effect among people who take Levetiracetam (levetiracetam), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Vimpat, and have Temporal lobe epilepsy.

The phase IV clinical study analyzes which people have Snoring when taking Levetiracetam. It is created by eHealthMe based on reports of 74,747 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly.

What is Levetiracetam?

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 75,294 Levetiracetam users. Check the latest studies of Levetiracetam.

What is Snoring?

Snoring is found to be associated with 614 drugs and 651 conditions by eHealthMe. Check the latest studies of Snoring.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

74,747 people reported to have side effects when taking Levetiracetam.
Among them, 36 people (0.05%) have Snoring.

Among these 36 people:

How long have people been on Levetiracetam when they have Snoring? *

What is the gender of people who have Snoring when taking Levetiracetam? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Snoring when taking Levetiracetam? *

What are other drugs people take besides Levetiracetam? *

What are other side effects people have besides Snoring? *

Sleep Apnea Syndrome: 15 people, 41.67%
Insomnia (sleeplessness): 12 people, 33.33%
Stress And Anxiety: 12 people, 33.33%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 10 people, 27.78%
Mood Swings (an extreme or rapid change in mood): 10 people, 27.78%
Fatigue (feeling of tiredness): 9 people, 25.00%
Nervousness: 8 people, 22.22%
Irregular Sleep Phase: 8 people, 22.22%
Terminal Insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired): 8 people, 22.22%
Depressed Mood: 8 people, 22.22%

What are the existing conditions these people have? *

Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 11 people, 30.56%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 11.11%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.33%
Localised Infection (infection at the single location): 2 people, 5.56%
Frontal Lobe Epilepsy (recurring seizures that arise in the frontal lobes of the brain): 2 people, 5.56%
Fatigue (feeling of tiredness): 2 people, 5.56%
Drowsiness: 2 people, 5.56%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 5.56%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 5.56%
Stress And Anxiety: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Levetiracetam and have Snoring?

- Check whether Snoring is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levetiracetam:

Levetiracetam (75,294 reports)

Snoring treatments and more:

Snoring (5,503 reports)

Browse all side effects of Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Snoring:

Snoring (614 drugs)

Browse all the conditions that are associated with Snoring:

Snoring (651 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.